Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis.
Siming LiXiaowen WuXieqiao YanLi ZhouZhihong ChiLu SiChuanliang CuiBixia TangLili MaoBin LianXuan WangXue BaiJie DaiYan KongXiongwen TangHui FengSheng YaoKeith T FlahertyJun GuoXinan ShengPublished in: Journal for immunotherapy of cancer (2022)
NCT03086174.